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Research
Numerous xenoestrogenic substances inter  act 
with estrogen receptor α (ERα) to initiate 
ERα-mediated events, including stimulation 
of cell responses such as proliferation and 
modulation of ERα-dependent gene regu-
lation (Moggs 2005). ERα can modulate 
gene expression by interacting directly with 
estrogen-responsive enhancer (ERE) DNA 
sequences in target genes and then recruiting 
necessary coregulatory factors to alter tran-
scription rates. Alternatively, ERα can affect 
the rate of transcription via inter  action with 
other DNA-binding transcription factors, such 
as AP-1 (activator protein 1) or Sp1 (specific-
ity protein-1), which then interact with their 
respective DNA motifs, leading to estrogen-
dependent control of target genes lacking 
EREs (Björnström and Sjöberg 2005; O’Lone 
et al. 2004). Because this second mecha  nism 
results in ERα being indirectly “tethered” to 
DNA motifs, it is sometimes referred to as the 
tethered mechanism. Studies have indicated 
that this tethered pathway is sensitive to xeno-
estrogenic endocrine-disrupting compounds 
(Fujimoto et al. 2004; Safe and Kim 2008; 
Wu et al. 2008).
Awareness of the potential for negative 
impact of exposures to chemicals has led 
investigators to focus on possible endocrine-
disrupting xeno  estrogenic chemicals, which 
disrupt or interfere with normal endocrine 
signals (Dey et al. 2009; Diamanti-Kandarakis 
et al. 2009; Gray et al. 2009; Miller et al. 
2006; Moggs 2005). One such chemical 
that can impact ERα responses is bisphe-
nol A (BPA). BPA was initially developed as 
a synthetic estrogen (Dodds et al. 1937) but 
subsequently has been used to manufacture 
poly  carbonate, a plastic polymer. BPA elic-
its ERα-dependent uterine weight increase 
(Markey et al. 2001), epithelial proliferation, 
and the up-regulation of insulin-like growth 
factor 1 (Igf-1) transcript (Klotz et al. 2000). 
Recent concern has developed regarding the 
potential nega  tive impacts of BPA because of 
its widespread use in poly  carbonate plastics in 
food containers.
2,2-bis(p-Hydroxyphenyl)-1,1,1-trichloro-
ethane (HPTE), an estrogenic metabo  lite of 
the pesticide methoxy  chlor, behaves similarly 
to estradiol (E2) and BPA in uterine response 
studies (Klotz et al. 2000; Newbold et al. 
2001). Much data has accumulated indicating 
that HPTE has biological estrogenic activities; 
however, open questions remain regarding 
the molecular players under  lying the biologi-
cal events. Methoxychlor has proven toxicity 
that affects ovarian functions (Borgeest et al. 
2002; Miller et al. 2006) and appears to cause 
these effects because of interactions with ERα, 
ERβ, and the androgen receptor (AR) (Gaido 
et al. 2000; Waters et al. 2001). More specifi-
cally, from in vitro cell studies, HPTE appears 
to exhibit agonist activity with ERα and 
antagonist activity with ERβ or AR (Gaido 
et al. 1999, 2000).
We have developed microarray profiling 
of the mouse uterus as a sensitive and compre-
hensive approach to study the direct targets of 
E2 and xeno  estrogens (Hewitt et al. 2003). By 
evaluating uterine transcript profiles of estro-
genic substances such as BPA and HPTE with 
our model system, we hope to understand the 
extent to which such compounds can initi-
ate ERα-mediated gene regulation or mediate 
other non-ERα responses. As part of our inves-
tigations into mechanisms of estrogen response 
in the mouse uterine model, we have used an 
ERα knock-in mouse that carries a mutation 
in its ERα, rendering it unable to directly 
bind to DNA, thus restricting it to the teth-
ered mode of ERα-mediated gene responses. 
Because female mice carrying one copy of the 
ERα knock in mutation are infertile, the line 
has been inter  crossed with the ERα knockout 
(αERKO) line to generate females with one 
knock-in (KI) and one knockout (KO) ERα 
allele (O’Brien et al. 2006). These mice are 
thus referred to as ERα KIKO. Our previ-
ous studies indicated that ERα KIKO mice 
selectively retain some uterine gene responses 
to E2 and also exhibit transcriptional responses 
unique to KIKO mice (Hewitt et al. 2009). 
Xenoestrogens also employ the tethered 
mecha  nism; therefore, gene profiles for BPA 
and HPTE in uteri of KIKO mice were evalu-
ated and compared with profiles of uteri from 
wild-type (WT) mice to determine whether 
these compounds are active via this mechanism 
in vivo and to see if BPA or HPTE exhibits any 
unique responses.
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Ba c k g r o u n d: Interest and concern regarding potentially estrogenic substances have resulted in 
development of model systems to evaluate mechanisms of such chemicals. Microarray studies have 
indicated that estradiol (E2)-stimulated uterine responses can be divided into early and late phases. 
Comparison of E2 uterine transcript profiles and those of other estrogenic chemicals of interest 
in vivo indicates mechanisms and activities of test compounds.
oBjectives: We compared transcript responses and mechanisms of response using mouse reproduc-
tive tracts after treatment with E2, estriol (E3), bisphenol A (BPA), and 2,2-bis(p-hydroxyphenyl)-
1,1,1-trichloroethane (HPTE). 
Me t h o d s : Uterine RNA from ovariectomized wild-type mice, estrogen receptor α (ERα) knock-
out (αERKO) mice, and mice expressing a DNA-binding–deficient ERα (KIKO) treated with E2, 
E3, BPA, or HPTE for 2 or 24 hr was analyzed by microarray. Resulting regulated transcripts were 
compared by hierarchical clustering and correlation analysis, and response patterns were verified by 
reverse-transcription real-time polymerase chain reaction (RT-PCR).
re s u l t s: Both xenoestrogens, BPA and HPTE, showed profiles highly correlated to that of E2 in 
the early response phase (2 hr), but the correlation diminished in the later response phase (24 hr), 
similar to the known weak estrogen E3. Both xeno  estrogens also mimicked E2 in samples from 
KIKO mice, indicating that they are able to utilize the indirect tethering mode of ERα signaling. 
No response was detected in ERα-null uteri, indicating that ERα mediates the responses.
co n c l u s i o n: Our study forms a basis on which patterns of response and molecular mechanisms of 
potentially estrogenic chemicals can be assessed.
key w o r d s : BPA, ERα, estrogen, HPTE, microarray, uterus. Environ Health Perspect 119:63–70   
(2011).  doi:10.1289/ehp.1002347 [Online 8 September 2010]Hewitt and Korach
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Materials and Methods
Animals. All animal studies were in accordance 
with National Institutes of Health guidelines 
(Institute of Laboratory Animal Resources 
1996) and an animal studies protocol approved 
by the National Institute of Environmental 
Health Sciences (NIEHS) Animal Care and 
Use Committee. The animals were treated 
humanely and with regard for alleviation of 
suffering.
Animals were either an ERα-null line 
(αERKO) (Lubahn et al. 1993), maintained 
at Taconic Farms (Germantown, NY), or were 
obtained by crossing the tethered-selective non-
classical ER knock-in (NERKI) hetero  zygous 
males (WT/KI) with αERKO hetero  zygous 
females (WT/KO). These crosses were done at 
Charles River (Wilmington, MA). Offspring 
were screened for the presence of the ERαKO 
and/or ERαKI alleles as previously described 
(Hewitt et al. 2009). Females that carried one 
copy each of the ERαKI and ERαKO alleles 
(KIKO), as well as ERα WT mice, were 
shipped to the NIEHS. Homozygous αERKO 
females were shipped from Taconic Farms. 
All mice were ovariectomized after reaching at 
least 10 weeks of age, rested for 10–14 days, 
and then used in studies.
Microarray. Ovariectomized WT, KIKO, 
and αERKO mice were injected intra-
peritoneally with 100 µL 0.85% saline/0.25% 
ethanol (EtOH) vehicle or with 2.5 µg/mL E2 
or estriol (E3) in 0.85% saline/0.25% EtOH 
(10 µg/kg body weight) for the E2 and E3 pro-
files. For the BPA and HPTE profiles, mice 
were injected sub  cutaneously with 100 µL 
4% EtOH/sesame oil (Sigma Chemical Co., 
St. Louis, MO) vehicle or 100 µL 7.5 mg/mL   
BPA (Sigma) or HPTE (kindly provided by 
W.N. Jefferson, NIEHS) dissolved in 4% 
EtOH/sesame oil. Both were used at a dose 
(750 µg/mouse or 30 mg/kg) that was pre-
viously selected to initiate IGF1 receptor–
mediated signaling as well as ERα-dependent 
uterine epithelial proliferation to a level 
comparable to that of E2 (Klotz et al. 2000). 
Tissue was collected after 2 or 24 hr of oil 
or saline vehicle, E2, E3, BPA, or HPTE 
injection because these time points have pre-
viously demon  strated a representative sam-
pling “snapshot” of ERα-dependent uterine 
gene responses at the two major phases of 
uterine actions (Hewitt et al. 2003). Uterine 
tissue (three to five uteri per group) was col-
lected and snap-frozen in liquid nitrogen, and 
RNA was prepared from the pooled tissue 
and analyzed as previously described (Hewitt 
et al. 2003). 
For E2, BPA, and HPTE, we conducted 
gene expression analyses using Agilent 
Mouse Oligo arrays (pattern 011978; Agilent 
Technologies, Palo Alto, CA) using two-color 
hybridization. Total RNA was amplified using 
the Agilent Low RNA Input Fluorescent 
Linear Amplification Kit protocol. Cy3 or 
Cy5-labeled cRNA was produced according to 
the manufacturer’s protocol from 500 ng total 
RNA per sample. For each two-color compari-
son, 750 ng each of Cy3 and Cy5-labeled 
cRNAs (oil or saline vehicle control and E2-, 
BPA-, or HPTE-treated from the same geno-
type) were mixed and fragmented using the 
100
80
60
40
20
0
U
t
e
r
i
n
e
 
w
e
i
g
h
t
 
(
m
g
)
V
V BPA HPTE E2 E3
E3 E2 BPA HPTE
* *
#
Figure 1. E2-, E3-, BPA-, and HPTE-mediated uterine growth responses. Photomicrographs 
showing Ki67 (A; bar = 100 µm) and phospho ser10 histone H3 (B; bar = 20 µm) in uterine tissue 
from mice treated 24 hr with oil vehicle (V), E2, E3, BPA, or HPTE. (C) Uterine weight (mean ± 
SD) of mice injected daily for 3 days with vehicle, E2, E3, BPA, or HPTE; uterine weights were 
collected on the fourth day.
*p < 0.05, and #p < 0.001, compared with vehicle, by one-way ANOVA and Tukey’s comparison; all treatment 
groups were significantly different (p < 0.001) from E2. Uterine microarray of BPA and HPTE
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Agilent In Situ Hybridization Kit (Agilent 
Technologies) following the manu  facturer’s 
protocol. Hybridizations were performed for 
17 hr in a rotating hybridi  za  tion oven using 
the Agilent 60-mer oligo micro  array process-
ing protocol. Two slides were hybridized for 
each sample pairing to allow for dye reversals 
(technical replicates). Slides were washed as 
indicated in the protocol and then scanned 
with an Agilent Scanner. Data were obtained 
using Agilent Feature Extraction software (ver-
sion 7.5), using defaults for all parameters. 
This software performed error modeling, 
adjusting for additive and multi  plicative noise. 
The resulting data were processed using the 
Rosetta Resolver system (version 7.2; Rosetta 
Biosoftware, Kirkland, WA). The ratio inten-
sity value for each gene feature on the array 
was averaged across technical replicates using 
the error-weighted approach described by 
Weng et al. (2006). A p-value for each gene 
probe was computed based on the reproduc-
ibility of the expression measurements across 
the technical replicates. Gene features with 
p < 0.001 were considered differentially 
expressed. Data were also filtered to exclude 
probes for which the signal intensity was not 
> 100 in any treatment. The resulting lists 
were combined and clustered hierarchically 
using Rosetta Resolver. 
For E3 gene expression, analy  sis was 
also conducted using Agilent Whole Mouse 
Genome 4 × 44 multiplex format oligo arrays 
(no. 014850; Agilent Technologies) follow-
ing the manu  facturer’s protocol for one-color 
micro  array-based gene expression analysis. 
Starting with 500 ng total RNA, Cy3-labeled 
cRNA was produced according to the manu-
facturer’s protocol. For each sample, 1.65 µg 
Cy3-labeled cRNA was fragmented and hybrid-
ized for 17 hr in a rotating hybridization oven. 
Slides were washed and then scanned with an 
Agilent Scanner. Data were obtained using 
Agilent Feature Extraction software (version 
9.5), using the one-color defaults for all param-
eters. This software performed error modeling, 
adjusting for additive and multiplicative noise. 
The resulting data were processed using the 
Rosetta Resolver system. All data have been 
deposited in the Gene Expression Omnibus 
(GEO; accession numbers GSE18168, 
GSE23241, and GSE24525; National Center 
for Biotechnology Information 2010).
Real-time polymerase chain reaction (PCR) 
to verify array findings. RNA was prepared 
from animals treated as described for micro-
array samples (three mice per treatment group). 
cDNA was prepared from individual uteri and 
analyzed by SYBR Green real-time PCR using 
methods and primers previously described 
(Hewitt et al. 2009, 2010). Computed val-
ues for each transcript were relative to WT 
saline vehicle. Means and SDs were calculated 
for the three sample group replicates in each 
treatment and ERα mouse line, and values 
were compared by one-way analysis of variance 
(ANOVA) and Tukey’s comparison. 
Immunohistochemistry. Formalin-fixed 
uterine pieces were embedded on end in paraf-
fin, and cross sections were cut in 4-µm slices, 
mounted on Superfrost charged slides (Fisher, 
Pittsburgh, PA), deparaffinized, and hydrated. 
Ki67 was detected as previously described 
(Hewitt et al. 2006). Phosphorylated serine 10 
(phospho ser10) histone H3 was detected 
using a similar method, except blocking buf-
fer contained 1.5% goat serum (Santa Cruz 
Biotechnology, Santa Cruz, CA), 1% bovine 
serum albumin, and primary antibody (catalog 
no. 06-570; Upstate Cell Signaling Solutions, 
Lake Placid, NY) diluted 1:500 in blocking 
buffer and was incubated on slides for 1 hr. 
Uterine weight bioassay. Ovariectomized 
WT mice were injected subcutaneously daily 
with 100 µL 4% EtOH/sesame oil vehicle 
or 2.5 µg/mL E2 or 2.5 µg/mL E3 in sesame 
oil/0.25% EtOH vehicle, or 7.5 mg/mL BPA 
or HPTE in 4% EtOH/sesame oil vehicle. At 
24 hr after the final injection, uteri were col-
lected and weighed (four animals per group).
Results
Biological responses. We evaluated the biologi-
cal response of the uterine tissues after 24 hr 
of treatment by detection of the prolifera-
tion marker Ki67 (Figure 1A). E2 is known 
to increase Ki67 in the uterine epithelia. The 
weak estrogen E3 (Clark and Markaverich 
1984; Katzenellenbogen 1984; Lan and 
Katzenellenbogen 1976) also increased the 
marker. Both xeno  estrogens, BPA and HPTE, 
led to increased Ki67 staining in the epithelial 
cells, reflecting a proliferative response, but the 
response is blunted compared with that of E2 
or E3. E2, E3, BPA, or HPTE did not increase 
Ki67 in KIKO epithelial cells, indicating a lack 
of proliferative stimulation (data not shown) 
and emphasizing a requirement for the DNA-
binding function of ERα for uterine growth. 
Further evaluation of WT tissue indicated mito-
sis by staining for phospho ser10 histone H3, a 
marker seen in peri  mitotic cells (Figure 1B). 
E2, E3, HPTE, and BPA resulted in increased 
detection of the marker in uterine epithelial 
cells, indicating that mitotic progression is 
stimulated by all three substances. Interestingly, 
when administered every 24 hr for 3 days, all 
compounds except BPA elicited a significant 
increase in uterine weight on the fourth day 
(Figure 1C), but the increase from HPTE or E3 
was significantly less than that from E2. 
Microarray analysis. Uterine gene profiles 
after administration of E2, E3, or the xeno-
estrogens BPA or HPTE to ovariectomized 
WT mice are shown as a heat map represent-
ing ratios of transcripts (ratio of treated to 
vehicle) that are significantly increased (red) 
or decreased (green) relative to the oil or saline 
vehicle controls after 2 or 24 hr (Figure 2). 
The 2-hr responses to E2, E3, BPA, and 
HPTE appeared to be very similar. Therefore, 
scatter  plots were generated using Rosetta 
Resolver software to compare regulated tran-
scripts in vehicle versus BPA or vehicle versus 
HPTE with vehicle versus E2. We observed 
a highly significant correlation between the 
compounds [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002347); correla-
tion coefficients of common signature genes 
are summarized in Table 1].
Figure 2. Microarray profile showing comparison of uterine gene response profiles 2 or 24 hr after treatment. 
Hierarchical clusters were built in Rosetta Resolver using cutoffs of p < 0.001 and at least a 2-fold change 
in expression in WT uteri after E2, E3, BPA, or HPTE treatment. Each horizontal row represents comparison 
of saline vehicle (V) and an estrogenic substance (E2, E3, BPA, or HPTE). Red and green indicate genes that 
were increased or decreased, respectively, relative to vehicle treatment. 
WT V vs. E2 2 hr
WT V vs. E2 24 hr
WT V vs. E3 2 hr
WT V vs. E3 24 hr
WT V vs. BPA 2 hr
WT V vs. BPA 24 hr
WT V vs. HPTE 2 hr
WT V vs. HPTE 24 hr
Table 1. Correlation of common signature genes 
in WT mice.
Oil vehicle
Saline vehicle Versus BPA Versus HPTE
Versus E2 2 hr 0.92 (3,400) 0.92 (3,143)
Versus E2 24 hr 0.61 (1,113)# 0.66 (2,022)#
Values are from scatter  plot analyses shown in Supple-
mental Material, Figure 1A (doi:10.1289/ehp.1002347). 
The number of common signature genes is shown in 
parentheses.
#Correlation coefficient is significantly lower (p < 0.001) 
than at 2 hr.Hewitt and Korach
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Comparisons of uterine transcript 
responses of tethered-selective ERα KIKO 
mice and WT mice to E2, BPA, or HPTE 
by micro  array [see Supplemental Material, 
Figure 2 (doi:10.1289/ehp.1002347)] indi-
cate that the KIKO response to all three com-
pounds is very similar. As previously reported 
for E2 (Hewitt et al. 2009), KIKO responses 
to all three compounds at 2 hr lack some of 
those seen in WT mice, indicating a require-
ment for DNA binding for those transcripts 
(see Supplemental Material, Figure 2A). Also 
as previously described for E2, transcripts 
unique to the KIKO profiles are apparent 
with all the compounds. Most responses are 
absent in the ERα-null αERKO profile at 
2 hr (see Supplemental Material, Figure 2A), 
indicating that the effects of the three com-
pounds are mediated by ERα (WT) or the 
DNA-binding mutant ERα (KIKO).
Comparisons of the E2-, BPA-, and 
HPTE-regulated KIKO transcripts using 
scatter  plots of the vehicle versus E2, com-
pared with vehicle versus BPA or vehicle ver-
sus HPTE resulted in correlation coefficients 
of common signature genes [summarized 
in Table 2; see also Supplemental Material, 
Figure 3 (doi:10.1289/ehp.1002347)]. Much 
like the WT responses, the responses of KIKO 
uteri to E2 and xeno  estrogens at 2 hr were 
highly correlated.
Unlike at the 2-hr time point, the WT 
responses to E3, BPA, and HPTE at 24 hr 
are less robust than responses to E2. The 
disparity between E2 and BPA or HPTE 
after 24 hr is apparent in the significantly 
decreased correlation coefficients obtained 
from a scatter  plot of signature genes [Table 1; 
see also Supplemental Material, Figure 2 
(doi:10.1289/ehp.1002347)]. The gene pro-
file seen after treating KIKO mice with E2, 
BPA, or HPTE for 24 hr indicates a weak 
response, with E2 showing the most apparent 
gene changes, whereas BPA and HPTE show 
little response [Table 2; see also Supplemental 
Material, Figure 2B). 
The differences in response to E2 between 
WT and KIKO mice noted in an earlier 
study (Hewitt et al. 2009) are also reflected 
here in the BPA and HPTE profiles [see 
Supplemental Material, Figure 2 (doi:10.1289/
ehp.1002347)]. Using a scatter  plot of WT 
vehicle versus E2 and KIKO vehicle versus 
E2 (Table 2; see also Supplemental Material, 
Figure 4) to compare these profiles indicates 
that responses to E2 compared with BPA 
or HPTE within an ERα genotype showed 
more correlation than when compared with 
WT and KIKO responses to E2. This empha-
sizes the estrogen-like mechanisms of BPA   
and HPTE.
Reverse-transcription real-time (RT)-PCR 
verification of micro  array observations. 
Overall, the micro  array profiles indicate that 
the xeno  estrogens, like the weak estrogen 
E3, were similar to E2 in eliciting early gene 
regu  la  tion but less effective in sustaining later 
responses. This observed trend was verified 
using RT-PCR evaluation transcripts identi-
fied in our previous studies as characteristic 
of early and late responses to E2 (Hewitt et al. 
2003, 2005, 2006, 2009). 
Stat5a, Inhbb, Mad2l1, and Ppp2r2c are 
all transcripts we have previously demon-
strated to be increased in the uterus 2 hr after 
E2 treatment in WT but not in KIKO or 
αERKO mice (Hewitt et al. 2009). All four of 
these transcripts were increased by E2 as well 
as by BPA and HPTE after 2 hr (Figure 3). 
None of the compounds could induce these 
four transcripts in KIKO or αERKO uteri, 
indicating that the responses rely on full 
activity of ERα. The xeno  estrogens were less 
effective than E2 in inducing Inhbb, Mad2l1, 
and Ppp2r2c, but HPTE was more effective 
than E2 in increasing Stat5a. We previously 
demonstrated the presence of an ERE in the 
Stat5a promoter, thus explaining the lack 
of response of this transcript to estrogens in 
KIKO mice (Hewitt et al. 2010b).
Previous analyses have demonstrated that 
Cdkn1a and Wnt4 transcripts can be increased 
by E2 in WT and KIKO uteri, indicating that 
their regulation involves the tethered mecha-
nism (Hewitt et al. 2009; O’Brien et al. 
2006). BPA and HPTE also increased Cdkn1a 
and Wnt4 transcripts in uteri of WT and 
KIKO mice but not in those of αERKO mice 
(Figure 3), indicating that these transcripts are 
regulated by indirect DNA binding. Sp1 bind-
ing sites have been identified in both promot-
ers (Ray et al. 2008; Yoshida et al. 2008). BPA 
and HPTE were as effective as E2 in increasing 
KIKO Wnt4 and WT Cdkn1a. However, in 
KIKO uteri, Cdkn1a induction by BPA or 
HPTE was significantly lower than induction 
by E2. Similarly, in WT uteri, the increase of 
Wnt4 after HPTE exposure was significantly 
lower than the the increase induced by E2. 
We have previously demon  strated that uterine 
Errfi1 is a target of E2 and increases in both 
WT and KIKO samples (Hewitt et al. 2009). 
Interestingly, BPA and HPTE also increased 
this transcript in KIKO and WT uteri; 
although the xenoestrogen-mediated increase 
in WT uteri is less robust than with E2, the 
increases with BPA and HPTE are equally as 
effective as those with E2 in KIKO uteri.
We previously showed that Sox8 (SRY-box 
containing gene 8) transcripts are selectively 
increased by E2 in KIKO but not WT uteri 
(Hewitt et al. 2009). In the present study, 
BPA and HPTE also increased Sox8 selec-
tively in KIKO uteri (Figure 3). E2 increased 
the KIKO Sox8 transcript more markedly 
than did BPA or HPTE. 
Nr4a1, Fos, Cyr61, and Gadd45g are ERα-
dependent, rapidly induced uterine transcripts 
(Hewitt et al. 2003, 2005, 2006, 2009). BPA 
and HPTE induced WT uterine Nr4a1, Fos, 
Cyr61, and Gadd45g transcripts (Figure 3), 
but not as robustly as did E2. E2 increases 
Nr4a1, Fos, and Cyr61 not only in KIKO but 
also in αERKO uteri (Hewitt et al. 2009), 
an effect that is likely mediated by residual 
ERα in KIKO and αERKO uteri from a 
splice variant, E1, that lacks the N-terminal 
AF-1 (activation function-1) domain of the 
ERα (Couse et al. 1995). Here, we found 
that BPA and HPTE increase Nr4a1, Fos, 
and Cyr61 transcripts in the KIKO but not 
in the αERKO samples (Figure 3). Thus, it 
appears that the residual activity mediated 
through the E1 splice variant in αERKO uteri 
after E2 treatment is not triggered by BPA 
or HPTE, suggesting that these compounds 
require the presence of the N-terminal AF-1 
region of the ERα. None of these compounds 
increased Nr4a1, Fos, or Cyr61 in uteri of 
Ex3αERKO, a complete ERα-null model 
that lacks the E1 splice variant (Hewitt et al. 
2010a) [see Supplemental Material, Figure 5 
(doi:10.1289/ehp.1002347)]. The increase 
in these transcripts was equally effective with 
E2 and the xeno  estrogens in this experi  ment 
(see Supplemental Material, Figure 5), unlike 
the previous experiment (Figure 3), in which 
xenoestrogens were less effective than E2. The 
background strain used in the second experi-
ment of WT litter  mates of the Ex3αERKO 
mice was predominantly C57bl/6, whereas 
the WT littermates of the KIKO mice were 
a mixture of C57bl/J and 129/SvJ, which 
might alter the sensitivity to or the metabo-
lism of the compounds. Despite the differ-
ence in relative effectiveness, these results still 
indicate that the N-terminal truncated ERα is 
insensitive to the xeno  estrogens and that the 
responses depend on ERα.
Gadd45g is rapidly and robustly increased 
in both WT and KIKO uteri by E2, BPA, and 
HPTE (Figure 3), but none of the compounds 
Table 2. Correlation of common signature genes in KIKO mice (vs. KIKO E2 or WT E2).
KIKO vehicle 
(saline)
KIKO vehicle (oil) WT saline vehicle 
versus E2 Versus BPA Versus HPTE
Versus E2 2 hr 0.93 (1,896) 0.93 (2,002) 0.77 (2,443)##
Versus E2 24 hr 0.05 (170)# 0.87 (349)# 0.63 (1,433)##
Values are from scatter  plot analyses shown in Supplemental Material, Figure 1B and 1C (doi:10.1289/ehp.1002347). The 
number of common signature genes is shown in parentheses.
#Correlation coefficient is significantly lower (p < 0.001) than at 2 hr. ##Correlation coefficient for WT vehicle versus 
E2 versus KIKO vehicle versus E2 is significantly lower (p < 0.001) than for KIKO vehicle versus E2 versus KIKO vehicle 
versus BPA or HPTE.Uterine microarray of BPA and HPTE
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is effective in αERKO uteri, indicating that 
the response requires ERα. The increase is 
greater with E2 in WT mice.
To validate the observed 24-hr gene 
responses, we selected transcripts that we 
have previously shown to be regulated by 
E2 (Hewitt et al. 2003, 2005, 2006). Ube2c, 
Ccnb2, Cdc2a, and Aurkb are all associated 
with the G2/M phases of the cell cycle, and 
are also all increased in the WT uterus by 
E2 after 24 hr. E2 causes little or no increase 
in these transcripts in KIKO uteri (Hewitt 
et al. 2010b), which correlated with the lack 
of uterine growth response. Dhcr24, a critical 
enzyme in cholesterol bio  synthesis, is simi-
larly a marker of uterine gene response to E2 
after 24 hr. BPA and HPTE also increased 
WT uterine Dhcr24, Ube2c, Ccnb2, Cdc2a, 
and Aurkb (Figure 4). The increased tran-
scription was greater with E2 than with the 
xeno  estrogens, with the exception of Ccnb2, 
which was increased equally by E2 or HPTE 
but exhibited reduced response to BPA. 
E2, BPA, or HPTE did not increase Ube2c, 
Ccnb2, Cdc2a, or Aurkb in KIKO uteri. 
KIKO Dhcr24 was significantly increased by 
E2 or BPA, but the E2 increase was mark-
edly less robust than that observed in WT 
uteri. Overall, analysis of previously charac-
terized ERα-dependent 24-hr uterine tran-
scripts confirms a trend of less responsiveness 
at the 24-hr time point with BPA and HPTE 
compared with E2 that is also reflected in the 
attenuated uterine growth (Figure 1B).
Potential xenoestrogen-selective transcripts 
could not be verified. Microarray transcript 
profiles suggest that some ERα-dependent 
gene responses might have been initiated by 
BPA and HPTE that were not observed with 
E2. We evaluated five apparent xeno  estrogen– 
up-regulated transcripts observed in the 
micro  array data by RT-PCR of indepen-
dent samples [see Supplemental Material, 
Figure 6 (doi:10.1289/ehp.1002347)]. Axin1 
(axis inhibi  tor 1), Per1 [period homolog 1 
(Drosophila)], and Gna12 (guanine nucleo  tide 
binding protein, alpha 12) were all increased 
by E2 as well as BPA and HPTE, whereas 
Mvp (major vault protein) was increased 
only by BPA, and Tnxb (tenascin XB) was 
not changed by any of the treatments. Thus, 
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Figure 3. RT-PCR of cDNA prepared from uterine RNA isolated from WT, KIKO, or αERKO mice treated with saline vehicle (V), E2, BPA, or HPTE for 2 hr. 
Abbreviations: Stat5a, signal transducer and activator of transcription 5A; Cdkn1a (p21), cyclin-dependent kinase inhibitor 1A (P21); Nr4a1, nuclear receptor sub-
family 4, group A, member 1; Inhbb, inhibin βb; Wnt4, wingless-related MMTV integration site 4; Fos, FBJ osteosarcoma oncogene; Mad2l1, MAD2 mitotic arrest 
deficient-like 2 (yeast); Errfi1 (MIG6), ERBB receptor feedback inhibitor 1; Cyr61, cysteine rich protein 61; Ppp2r2c (PP2A), protein phosphatase 2 (formerly 2A), regu-
latory subunit B (PR 52), gamma isoform; Sox8, SRY-box containing gene 8; Gadd45g, growth arrest and DNA-damage-inducible 45. Values are calibrated rela  tive to 
ribosomal protein L7 (PL-7) and are plotted relative to WT vehicle levels for each transcript; results were analyzed by two-way ANOVA with a post t-test.
ap < 0.01 relative to E2. **p < 0.01 relative to the vehicle within the genotype. Hewitt and Korach
68  v o l u m e  119 | n u m b e r 1 | January 2011  •  Environmental Health Perspectives
except for Mvp, none of these genes repro-
duced the apparent selective xeno  estrogen 
regula  tion that we observed in the micro  array 
data that were evaluated by RT-PCR with 
independent samples.
Discussion
Numerous studies have assessed poten-
tial estrogenicity of BPA and HPTE using 
models more amenable to toxicological and 
risk assessment (Myers et al. 2009; Tiemann 
2008; Vandenberg et al. 2007, 2009; vom 
Saal et al. 2007). Additionally, chemical mod-
eling studies have indicated possible modes 
of inter  action between BPA or HPTE with 
ERα compared with E2 and other estrogens 
(Celik et al. 2008). Other approaches that use 
in vitro models have been useful in indicat-
ing modes of ER-mediated response (Gaido 
et al. 1999, 2000; Safe et al. 2001; Yoon et al. 
2000) but do not reflect the global transcrip-
tional events or endogenous gene transcrip-
tional regulation. Previous micro  array studies 
have examined prolonged exposures of uterine 
tissues (Ashby and Odum 2004; Waters et al. 
2001) or used cell culture models (Boehme 
et al. 2009). Our approach differed from these 
both in method and in purpose. In our study 
we used methods optimized to be highly estro-
gen sensitive, not necessarily to address health 
effects or to address chemical properties, but to 
indicate aspects of mechanisms and response 
of these chemicals directly mediated by ERs. 
Accordingly, although the BPA and HPTE 
doses were relatively high, they were previously 
shown to be the minimum doses effective in 
initiating uterine responses of IGF1 recep-
tor activation and epithelial cell prolifera  tion 
(Klotz et al. 2000) to a degree comparable to 
that of E2. Similarly, in vitro studies have indi-
cated doses of 75 µM BPA and 25 µM HPTE 
were needed for a reporter gene response to 
match that of 10 nM E2 (Safe and Kim 2008).
Initially, we used micro  array to assess the 
gene profiles of E2 compared with two endo-
crine disruptors: BPA, which is polymerized 
to produce poly  carbonate plastics, and HPTE, 
which is a metabolite of the pesticide meth-
oxychlor. Both chemicals have been shown 
to stimulate uterine prolifera  tion in an ERα-
dependent manner (Klotz et al. 2000), which 
we further confirmed here and extended to 
include evalua  tion of Ki67 (a general marker 
of cell proliferation) and phospho ser10 his-
tone H3 (a marker of peri  mitosis) in addi-
tion to uterine weight increase after 72 hr. 
Interestingly, both BPA and HPTE were less 
effective than the established weak estrogen 
E3 in stimulating Ki67, but they were similar 
to E3 in all other indicators of uterine growth 
response. In agreement with a mode similar to 
the weak estrogen E3, the early (2-hr) gene pro-
files were very similar between E3 and E2, BPA, 
or HPTE and further showed dependence 
on ERα, indicating that these compounds 
are interacting with ERα to induce transcrip-
tional responses in the uterine tissue. The gene 
profiles add to a growing body of data that 
demonstrate ERα-mediated estrogenic activi-
ties in a manner that reflects a massive global 
transcriptional activity that is very highly cor-
related to the gene responses mediated by E2. 
The reconfirmation of some of these early 
phase transcripts by RT-PCR indicates that 
BPA and HPTE are able to regulate uterine 
transcripts through a mecha  nism that requires 
ERα and can use either direct ERE binding or 
tethered inter  action with target genes. Previous 
work has demon  strated that there are several 
E2-induced transcripts in the uteri of ERα-null 
αERKO mice. These responses are mediated 
by a truncated E1 ERα mole  cule that lacks the 
AF-1 region (Couse et al. 1995; Hewitt et al. 
2009). In the present study, we observed that 
these E1-responsive transcripts are not sensi-
tive to BPA or HPTE, a novel finding indicat-
ing that these compounds rely on the AF-1 
cofactor binding region of the ERα. These are 
compelling findings, suggesting that exposures 
to chemicals such as BPA or HPTE have the 
potential to profoundly affect exposed individ-
uals by interfering with endogenous estrogens 
or by initiating inappropriate estrogenic effects.
We found that the intensities of later 
(24 hr) E3, BPA, and HPTE responses in the 
gene profiles were reduced relative to E2; this 
suggests that these compounds are weaker 
than E2 in their ability to sustain a response. 
Indeed, the gene profiles of BPA and HPTE 
were very similar to that of E3, a known weak 
or impeded estrogen (Clark and Markaverich 
1984; Katzenellenbogen 1984). We verified 
this observed effect by RT-PCR, showing that 
the xeno  estrogens can induce early transcripts 
similar to E2 and that later responses were 
attenuated. The decrease in the later responses 
may result from the rates of metabo  lism or 
how well BPA and HPTE maintain inter-
action with ERα, as is seen with E3, where 
retention of nuclear binding and RNA poly-
merase II activities are similar early after injec-
tion but are not maintained as long as E2 
responses (Clark and Markaverich 1984).
Some transcript responses in the array 
analysis were apparently unique to the xeno-
estrogens. Further analysis of signal intensities 
of these arrays indicated altered basal signal 
Figure 4. RT-PCR of cDNA prepared from uterine RNA isolated from WT, KIKO, or αERKO mice treated with saline vehicle (V), E2, BPA, or HPTE for 24 hr. 
Abbreviations: Dhcr24, 24-dehydrocholesterol reductase; Ube2c, ubiquitin-conjugating enzyme E2C; Ccnb2 cyclin B2; Cdc2a, cell division cycle 2 homolog A 
(S. pombe); Aurkb, aurora kinase B. Values are calibrated relative to ribosomal protein L7 (PL-7) and are plotted relative to WT vehicle levels for each transcript; 
results were analyzed by two-way ANOVA with a post t-test.
ap < 0.01 relative to E2. **p < 0.01 relative to the vehicle within the genotype. 
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intensity levels of the vehicle channel of BPA 
and HPTE for about 5–10% of the transcripts 
in these clusters, representing these hypo-
thetical xenoestrogen-regulated transcripts 
(data not shown), which gives the appearance 
that xeno  estrogens are regulating these tran-
scripts compared with the altered baseline. 
Consistent with this, except for one example 
(Mvp), xenoestrogen-selective responses could 
not be verified by independent RT-PCR. 
Additionally, we recently repeated this experi-
ment with new samples and no longer saw 
these patterns (data not shown; GEO acces-
sion no. GSE24525). Our results indicate 
that BPA and HPTE primarily signal through 
mecha  nisms mediated by ERα.
We have previously reported that some 
of the late response genes are associated with 
G2–M progression, as would be expected to 
occur as part of the uterine growth response 
(Hewitt et al. 2003, 2009). BPA and HPTE 
are less able to mediate some of these tran-
scripts, including Cdc2a and Aurkb (Figure 4), 
whereas BPA is less able to induce Ccnb2. The 
inability of BPA and HPTE to maintain the 
responses is also reflected in the less intense 
Ki67 level (Figure 1A) as well as lower maxi-
mal uterine weight obtained in 3-day uterine 
bio  assays (Figure 1B) (Markey et al. 2001; 
Newbold et al. 2001).
Overall, the analysis of KIKO responses 
[which are restricted to the ERE-independent 
mode of ERα-dependent response (Jakacka 
et al. 2001; O’Brien et al. 2006)] to the   
endocrine-disrupting chemicals (BPA, HPTE) 
indicated similarity with the KIKO response to 
E2, confirming the sensitivity of this mode of 
ERα signaling for xeno  estrogenic compounds. 
It is interesting that the pattern of response to 
E2 or xeno  strogen is more highly correlated 
within each geno  type (WT or KIKO) than 
with chemical identity, which emphasizes the 
similarity of the activity of these chemicals to 
estrogens and the potential for effects in vivo. 
The differences between WT and KIKO 
gene profiles were the focus of a previously 
published study (Hewitt et al. 2009). In that 
study, analyses of the E2 responses in KIKO 
uteri indicated that some pathways (e.g., JAK/
STAT signaling) are regulated similarly in WT 
and KIKO uteri, whereas others (e.g., WNT/
β-catenin signaling) are impacted in both WT 
and KIKO uteri; however, the outcome is 
altered in KIKO compared with the WT uteri 
because different members of the pathway are 
affected or regulated in opposite directions.   
In the present study, these differences were 
also observed with BPA and HPTE. For 
example, the Ppp2r2c transcript, encoding an 
important activator of β-catenin (CTNNB1) 
transcriptional activity (Gordon and Nusse 
2006), was increased in WT uteri by E2, as 
well as by BPA and HPTE (Figure 3), but 
was not changed in KIKO mice by any of the 
treatments. Conversely, Sox8, which encodes 
an inhibitor of CTNNB1-mediated tran-
scription (Gordon and Nusse 2006), was not 
changed in WT uteri but was increased by all 
three treatments in KIKO uteri (Figure 3). 
The observed KIKO-selective transcript regu-
lation, such as the increase in Sox8, suggests a 
complex mecha  nism of regulation or, alterna-
tively, indicates that the cells of the KIKO 
uterus have developed abnormal signaling 
pathways. At this point, our study does not 
address reasons for the unique and unexpected 
KIKO uterine transcript profile. However, the 
fact that BPA and HPTE elicited the same 
unique KIKO uterine transcript profiles as 
E2 supports the idea that their activity and 
mechanism resemble those of E2. Thus, here 
we present a novel in vivo study indicating 
that, as previously described using in vitro 
cell culture systems (Fujimoto et al. 2004; 
Safe and Kim 2008; Wu et al. 2008), the 
tethered response mechanism is sensitive to 
xeno  estrogen compounds.
Conclusion 
Our study was designed to evaluate the mech-
anistic aspects of xeno  estrogenic chemicals in 
an in vivo system and their impact through 
ERα signaling on biological processes. We 
observed clear similarities between the xeno-
estrogens tested and E2—especially in the 
2-hr treatment group—in the micro  array pro-
files, and we verified these observations by 
RT-PCR. Our findings and the availability 
of the micro  array data set will be useful in the 
develop  ment of a panel of biomarker uterine 
transcripts for future evaluation of modes of 
action and mechanisms of other potentially 
estrogenic chemicals.
RefeRences
Ashby J, Odum J. 2004. Gene expression changes in the imma-
ture rat uterus: effects of uterotrophic and sub-uterotrophic 
doses of bisphenol A. Toxicol Sci 82(2):458–467.
Björnström L, Sjöberg M. 2005. Mechanisms of estrogen recep-
tor signaling: convergence of genomic and non  genomic 
actions on target genes. Mol Endocrinol 19(4):833–842.
Boehme K, Simon S, Mueller SO. 2009. Gene expression profil-
ing in Ishikawa cells: a fingerprint for estrogen active 
compounds. Toxicol Appl Pharmacol 236(1):85–96.
Borgeest C, Symonds D, Mayer LP, Hoyer PB, Flaws JA. 2002. 
Methoxychlor may cause ovarian follicular atresia and 
proliferation of the ovarian epithelium in the mouse. 
Toxicol Sci 68(2):473–478.
Celik L, Lund JDD, Schiøtt B. 2008. Exploring interactions of 
endocrine-disrupting compounds with different conforma-
tions of the human estrogen receptor α ligand binding 
domain: a molecular docking study. Chem Res Toxicol 
21(11):2195–2206.
Clark JH, Markaverich BM. 1984. The agonistic and antago-
nistic actions of estriol. J Steroid Biochem Mol Biol 
20(4B):1005–1013.
Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, 
Lubahn DB, et al. 1995. Analysis of transcription and estrogen 
insensitivity in the female mouse after targeted disruption of 
the estrogen receptor gene. Mol Endocrinol 9:1441–1454.
Dey S, Soliman AS, Merajver SD. 2009. Xenoestrogens may 
be the cause of high and increasing rates of hormone 
receptor positive breast cancer in the world. Med Hypoth 
72(6):652–656.
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, 
Prins GS, Soto AM, et al. 2009. Endocrine-disrupting chemi-
cals: an endocrine society scientific statement. Endocr Rev 
30(4):293–342.
Dodds EC, Fitzgerald MEH, Lawson W. 1937. Oestrogenic activ-
ity of some hydrocarbon derivatives of ethylene. Nature 
140:772–772.
Fujimoto N, Honda H, Kitamura S. 2004. Effects of environmen-
tal estrogenic chemicals on AP1 mediated transcription 
with estrogen receptors α and β. J Steroid Biochem Mol 
Biol 88(1):53–59.
Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, 
Saville B, et al. 1999. Differential interaction of the 
methoxy  chlor metabolite 2,2-bis-(p-hydroxyphenyl)-
1,1,1-trichloroethane with estrogen receptors α and β. 
Endocrinology 140(12):5746–5753. 
Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, 
Safe S. 2000. Interaction of methoxychlor and related 
compounds with estrogen receptor α and β, and andro-
gen receptor: structure-activity studies. Mol Pharmacol 
58(4):852–858.
Gordon MD, Nusse R. 2006. Wnt signaling: multiple pathways, 
multiple receptors, and multiple transcription factors. J Biol 
Chem 281(32):22429–22433.
Gray J, Evans N, Taylor B, Rizzo J, Walker M. 2009. State of the 
evidence: the connection between breast cancer and the 
environment. Int J Occup Environ Health 15(1):43–78.
Hewitt SC, Collins J, Grissom S, Deroo B, Korach KS. 2005. 
Global uterine genomics in vivo: microarray evaluation of 
the estrogen receptor α-growth factor cross-talk mecha-
nism. Mol Endocrinol 19(3):657–668.
Hewitt SC, Collins J, Grissom S, Hamilton K, Korach KS. 
2006. Estren behaves as a weak estrogen rather than 
a non  genomic selective activator in the mouse uterus. 
Endocrinology 147(5):2203–2214.
Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA, 
et al. 2003. Estrogen receptor-dependent genomic responses 
in the uterus mirror the biphasic physio  logical response to 
estrogen. Mol Endocrinol 17(10):2070–2083.
Hewitt, SC, Kissling GE, Fieselman KE, Jayes FL, Gerrish KE, 
Korach KS. 2010a. Biological and biochemical conse-
quences of global deletion of exon 3 from the ERα gene. 
FASEB J 24(12):4660–4667; doi: 10.1096/fj.10-163428 [Online 
28 July 2010].
Hewitt SC, Li Y, Li L, Korach KS. 2010b. Estrogen-mediated 
regulation of Igf1 transcription and uterine growth involves 
direct binding of estrogen receptor α to estrogen-respon-
sive elements. J Biol Chem 285(4):2676–2685. 
Hewitt SC, O’Brien JE, Jameson JL, Kissling GE, Korach KS. 
2009. Selective disruption of ER α DNA-binding activity 
alters uterine responsiveness to estradiol. Mol Endocrinol 
23(12):2111–2116.
Institute of Laboratory Animal Resources. 1996. Guide for 
the Care and Use of Laboratory Animals. Washington, 
DC:National Academy Press. Available: http://oacu.od.nih.
gov/regs/guide/guide.pdf [accessed 1 November 2010]. 
Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. 
2001. Estrogen receptor binding to DNA is not required for 
its activity through the nonclassical AP1 pathway. J Biol 
Chem 276(17):13615–13621.
Katzenellenbogen BS. 1984. Biology and receptor inter  actions 
of estriol and estriol derivatives in vitro and in vivo. 
J Steroid Biochem 20(4b):1033–1037.
Klotz DM, Hewitt SC, Korach KS, Diaugustine RP. 2000. Activation 
of a uterine insulin-like growth factor I signaling pathway by 
clinical and environmental estrogens: requirement of estro-
gen receptor-α. Endocrinology 141(9):3430–3439.
Lan NC, Katzenellenbogen BS. 1976. Temporal relation-
ships between hormone receptor binding and biological 
responses in the uterus: studies with short- and long-acting 
derivatives of estriol. Endocrinology 98(1):220–227.
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, 
Smithies O. 1993. Alteration of reproductive function but not 
prenatal sexual development after insertional disruption of 
the mouse estrogen receptor gene. Proc Natl Acad Sci USA 
90(23):11162–11166.
Markey CM, Michaelson CL, Veson EC, Sonnenschein C, 
Soto AM. 2001. The mouse uterotrophic assay: a reevalua-
tion of its validity in assessing the estrogenicity of bisphe-
nol A. Environ Health Perspect 109:55–60.
Miller KR, Gupta RK, Flaws JA. 2006. Methoxychlor metabolites 
may cause ovarian toxicity through estrogen-regulated 
pathways. Toxicol Sci 93(1):180–188.
Moggs JG. 2005. Molecular responses to xenoestrogens: Hewitt and Korach
70  v o l u m e  119 | n u m b e r 1 | January 2011  •  Environmental Health Perspectives
mechanistic insights from toxicogenomics. Toxicology 
213(3):177–193.
Myers JP, vom Saal FS, Akingbemi BT, Arizono K, Belcher S, 
Colborn T, et al. 2009. Why public health agencies cannot 
depend on Good Laboratory Practices as a criterion for 
selecting data: the case of bisphenol A. Environ Health 
Perspect 117:309–315.
National Center for Biotechnology Information. 2010. Gene 
Expression Omnibus. Available: http://www.ncbi.nlm.nih.
gov/geo/ [accessed 2 November 2010]. 
Newbold RR, Jefferson WN, Padilla-Banks E, Walker VR, 
Pena DS. 2001. Cell response endpoints enhance sensi-
tivity of the immature mouse uterotropic assay. Reprod 
Toxicol 15(3):245–252.
O’Brien JE, Peterson TJ, Tong MH, Lee EJ, Pfaff LE, Hewitt SC, 
et al. 2006. Estrogen-induced proliferation of uterine epi-
thelial cells is independent of estrogen receptor α binding 
to classical estrogen response elements. J Biol Chem 
281(36):26683–26692.
O’Lone R, Frith MC, Karlsson EK, Hansen U. 2004. Genomic 
targets of nuclear estrogen receptors. Mol Endocrinol 
18(8):1859–1875.
Ray S, Xu F, Wang H, Das SK. 2008. Cooperative control via 
lymphoid enhancer factor 1/t cell factor 3 and estrogen 
receptor-α for uterine gene regulation by estrogen. Mol 
Endocrinol 22(5):1125–1140.
Safe S, Kim K. 2008. Non-classical genomic estrogen receptor 
(ER)/specificity protein and ER/activating protein-1 signal-
ing pathways. J Mol Endocrinol 41(5–6):263–275.
Safe SH, Pallaroni L, Yoon K, Gaido K, Ross S, Saville B, et al. 
2001. Toxicology of environmental estrogens. Reprod Fertil 
Dev 13(4):307–315.
Tiemann U. 2008. In vivo and in vitro effects of the organochlo-
rine pesticides DDT, TCPM, methoxychlor, and lindane 
on the female reproductive tract of mammals: a review. 
Reprod Toxicol 25(3):316–326.
Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 
2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 
24(2):139–177.
Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, 
Soto AM. 2009. Bisphenol-A and the great divide: a review 
of controversies in the field of endocrine disruption. 
Endocr Rev 30(1):75–95.
vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, 
Crain DA, Eriksen M, et al. 2007. Chapel Hill bisphenol   
A expert panel consensus statement: integration of 
mechanisms, effects in animals and potential to impact 
human health at current levels of exposure. Reprod Toxicol 
24(2):131–138.
Waters KM, Safe S, Gaido KW. 2001. Differential gene expres-
sion in response to methoxychlor and estradiol through 
ER α, ER β, and AR in reproductive tissues of female mice. 
Toxicol Sci 63(1):47–56.
Weng L, Dai HY, Zhan YH, He YD, Stepaniants SB, Bassett DE. 
2006. Rosetta error model for gene expression analysis. 
Bioinformatics 22(9):1111–1121.
Wu F, Khan S, Wu Q, Barhoumi R, Burghardt R, Safe S. 2008. 
Ligand structure-dependent activation of estrogen receptor 
α/Sp by estrogens and xeno  estrogens. J Steroid Biochem 
Mol Biol 110(1–2):104–115.
Yoon K, Pellaroni L, Ramamoorthy K, Gaido K, Safe S. 2000. Ligand 
structure-dependent differences in activation of estrogen 
receptor α in human HepG2 liver and U2 osteogenic cancer 
cell lines. Mol Cell Endocrinol 162(1–2):211–220.
Yoshida T, Kitaura H, Hagio Y, Sato T, Iguchi-Ariga SMM, Ariga H. 
2008. Negative regulation of the Wnt signal by MM-1 
through inhibiting expression of the wnt4 gene. Exp Cell Res 
314(6):1217–1228. 